is not yet possible to conclude absolutely that the ICSI procedure might induce some altered development or that the ICSI protocol might not be improved even further. To address this in a clinically relevant system, the developmental potential of rhesus monkey embryos produced by ICSI is reported. Oocytes collected by laparoscopy from gonadotrophin-stimulated fertile females were fertilized by ICSI using spermatozoa obtained from fertile males by electro-ejaculation. Neither sperm immobilization prior to injection nor an additional chemical stimulus were necessary to achieve oocyte activation and pronuclear formation. Survival and activation of the injected oocytes were judged by the extrusion of the second polar body. Successful fertilization was confirmed by the presence of two pronuclei within 12 h post-ICSI. Some oocytes were fixed and processed for the detection of microtubules and chromatin. Fluorescent labelling revealed that by 12 h post-ICSI the male and female pronuclei were closely apposed and eccentrically positioned within a large microtubule aster. ICSI resulted in a 76.6 Ϯ 14.9% fertilization rate. First cleavage was completed within 24 h post-ICSI. Two-cell ICSI embryos were co-cultured in CMRL medium on a buffalo rat liver cell monolayer until the hatched blastocyst stage. Oocytes collected laparoscopically from stimulated monkeys can be fertilized by ICSI and will complete preimplantation embryo development in vitro demonstrating that the rhesus monkey is an excellent preclinical model for examining and understanding many aspects of human ICSI.
Introduction
The clinical introduction of intracytoplasmic sperm injection (ICSI; Palermo et al., 1992) revolutionized methods of assisted reproduction. More recently ICSI has been extended to include immature spermatozoa Schlegel et al., 1997) or spermatozoa with abnormal morphology Liu et al., 1995; Nagy et al., 1995; Tournaye et al., 1996) even though ICSI using suboptimal spermatozoa may pose a long-term risk to the offspring (In't Veld et al., 1995; Silber et al., 1995; Kent-First et al., 1996 ; reviewed by Vogt, 1995) . In some extreme cases, spermatozoa showing spermatogenic impairment have been used to achieve fertilization by ICSI (Mulhall et al., 1997) but this leads to concerns that achieving pregnancies in couples with extreme male factor infertility may be perpetuating the same or similar fertility problems in the next generation (Patrizio, 1995; Silber et al., 1995; Cummins, 1997; Schatten et al., 1998) . Furthermore, evidence of increased genetic abnormalities following human ICSI have recently been reported (Bonduelle et al., 1995 (Bonduelle et al., , 1998 , though it is not yet possible to ascribe relative problems associated with male factor infertility versus the ICSI procedure itself. These concerns underscore the need to perform conclusive pre-clinical studies to understand the biochemical, cellular, developmental and genetic consequences of ICSI in a relevant animal model (Ng et al., 1995; Patrizio, 1995; Cummins and Jequier, 1995; Yanagimachi, 1995) ; however, the selection of a model in which to study ICSI has been challenging. The survival of mouse oocytes after ICSI is low (Ron-El et al., 1995) without the aid of a piezo-driven microinjection pipette for sperm injection (Kimura and Yanagimachi, 1995) and although hamsters are a good model for understanding pronuclear formation after ICSI (Uehara and Yanagimachi, 1976; Westhusin and Kraemer, 1986) , their use is hampered because of the difficulty in culturing manipulated hamster oocytes to the desired stage for embryo transfer. Furthermore, fertilization in rodents is dependent on maternal centrosomes (Schatten et al., 1985) , whereas in humans the centrosome is paternallyderived (reviewed by Schatten, 1994; Simerly et al., 1995) . This is especially relevant with regard to heterologous ICSI to assay sperm function (Asada et al., 1995) , since human spermatozoa injected into hamster oocytes will not nucleate microtubules (Hewitson et al., 1997) , as they do after injection into human oocytes (Asch et al., 1995) . Rabbits have been successfully used to produce ICSI offspring (Iritani, 1988) but have not been routinely used as a model for studying human ICSI. Bovine ICSI has proved to be technically challenging (Hewitson et al., 1996a ) with low success rates (Younis et al., 1989) and has so far resulted in the birth of only one calf (Goto et al., 1990) . Furthermore, bovine oocytes are unable to complete meiotic maturation after ICSI and require an additional chemical stimulus such as incubation in calcium ionophore (Keefer et al., 1990) .
Non-human primates represent a valuable resource for studying human reproduction. Gamete maturation, in-vitro fertilization (IVF), embryonic development, embryo transfer and implantation have been well documented in a variety of non-human primates (Enders et al., 1983; Bavister et al., 1983; 1984; Lopata et al., 1988; Lanzendorf et al., 1990; VandeVoort and Tarantal, 1991; Wu et al., 1996 ; reviewed by Wolf et al., 1989) and are considered good models for studying human reproduction. Furthermore, centrosomal inheritance and fertilization in the rhesus monkey (Wu et al., 1996) has been shown to be almost identical to that of humans . The first report of ICSI in a non-human primate demonstrated limited success using in-vitro matured rhesus oocytes isolated from females undergoing ovariectomy (Hewitson et al., 1996b) . Furthermore, immature oocytes matured in vitro and fertilized by ICSI displayed many cytoskeletal abnormalities, some of which mimicked those documented after human IVF and ICSI (Asch et al., 1995; Simerly et al., 1995) . The present study was undertaken to investigate the ability of mature rhesus oocytes, collected by laparoscopy from gonadotrophin-stimulated females and fertilized by ICSI, to complete embryonic development in vitro.
Materials and methods

Oocyte and sperm collection
Hyperstimulation of female rhesus macaques exhibiting normal menstrual cycles was induced by a regimen of exogenous gonadotrophic hormones (Zelinski-Wooten et al., 1995; Meng and Wolf, 1997) . Females were down-regulated by daily subcutaneous injections of a gonadotrophin-releasing hormone (GnRH) antagonist (Antide ® ; Ares Serono, Randolph, MA, USA) at 0.5 mg/kg body weight for 6 days during which recombinant human follicle stimulating hormone (FSH) (r-HFSH; Organon Inc., West Orange, NJ, USA) was administered twice daily (30 IU, i.m.). This was followed by 1-3 days of r.HFSH ϩ r-HLH (30 IU each, i.m., twice daily). Ultrasonography was performed on day 7 to confirm adequate follicular development. When there were at least four follicles ജ4 mm in diameter, a final i.m. injection of 1000 IU r-HCG (Serono) was administered. Follicles were aspirated by laparoscopy 27 h post-HCG injection and the collected oocytes immediately assessed for nuclear maturity. Immature oocytes that had undergone germinal vesicle breakdown (GVBD) were cultured at 37°C in pre-equilibrated microdrops of modified CMRL-1066 medium (Boatman, 1987) supplemented with 10 µg/ml porcine FSH (Serono) and 5 IU/ml HCG (Serono) to support maturation to metaphase II arrest. Mature rhesus oocytes were cultured for up to 6 h in pre-equilibrated TALP medium containing 3 mg/ml BSA (Bavister et al., 1983) prior to fertilization. Semen, collected by penile electro-ejaculation (Hewitson et al., 1996b) from four rhesus males of demonstrated fertility, was washed thoroughly in TALP-HEPES, resuspended at 20ϫ10 6 spermatozoa/ml in equilibrated TALP and cultured at 37°C for up to 6 h prior to use for ICSI.
Intracytoplasmic sperm injection of rhesus oocytes
Holding pipettes were flame-polished with an external diameter of 100 µm and internal diameter of 20 µm. Injection pipettes (Humagen, Charlottesville, VA, USA) were bevelled to 50°with an outer diameter of 6-7 µm and an internal diameter 4-5 µm. All manipulation procedures were performed at 32°C in 100 µl TALP-HEPES under mineral oil (Sigma Chemical Co., St Louis, MO, USA). Washed spermatozoa were diluted 1:50 in 10% polyvinylpyrrolidone (PVP; Sigma) to reduce motility. A single spermatozoon was aspirated tailfirst from the spermatozoa-PVP drop. Oocytes immobilized with the polar body in the 12 o'clock position were injected as previously described (Hewitson et al., 1996b) . Gentle aspiration of the cytoplasm assured that the oolemma had been breached prior to the release of the spermatozoon. Injected oocytes were washed in equilibrated TALP and returned to culture in 100 µl TALP overlaid with oil at 37°C in 5% CO 2 .
Assessment of fertilization and embryo culture
Oocytes were examined between 10-12 h post-sperm injection using Hoffman modulation contrast optics and the number of pronuclei recorded. Oocytes containing two pronuclei and two polar bodies were considered fertilized and maintained in culture until the 2-cell stage (24-28 h post-injection). For subsequent embryo culture, buffalo rat liver cells (BRL 1442; American Type Culture Collection, Rockville, MD, USA) were suspended in CMRL medium containing 10% FCS (Hyclone Laboratories Inc., Logan, UT, USA) and seeded in 100 µl drops overlain with oil (Zhang et al., 1994) . Two-cell embryos were cultured in CMRL on buffalo rat liver cell monolayers at 37°C in 5% CO 2 and scored for development daily.
Microtubule and DNA imaging
Some of the injected oocytes were randomly selected during fertilization or subsequent embryo culture and processed for the immunocytochemical detection of microtubules and DNA. Zonae pellucidae were removed by a 1-2 min incubation in 0.1% pronase (CalBiochem Corp.; San Diego, CA, USA). After a 30 min recovery period at 37°C, injected oocytes were fixed in absolute methanol at 10°C (Simerly and Schatten, 1993) . To visualize microtubules, oocytes were incubated for 1 h in a mouse monoclonal antibody to β-tubulin (E7). After a 40 min incubation, oocytes were rinsed in PBS and 0.1% Triton X-100 detergent for 20 min. E7 was detected using a FITC conjugated goat anti-mouse IgG secondary antibody (1:40; Zymed, San Francisco, CA, USA). DNA was labelled by the addition of 5 µg/ml DAPI (Sigma) to the penultimate rinse. Coverslips were mounted in an antifade medium (Vectashield ® ; Vector Labs, Burlinghame, CA, USA) to retard photobleaching. Conventional epifluorescent microscopy was performed using a Zeiss Axiphot ® microscope. Images were digitally recorded with a chilled CCD camera (Princeton Instruments Inc., Trenton, NJ, USA) using Metamorph imaging software (Universal Imaging, West Chester, PA, USA). Images were archived on recordable CDs, processed using Adobe Photoshop software (Adobe Systems Inc., MountainView, CA, USA) and printed on a dye sublimation printer (Sony Corp., NY, USA).
Results
A total of 216 oocytes were retrieved by laparoscopy from eight stimulated females, 26-28 h post-HCG injection. Oocyte maturity at the time of collection was as follows: 30 (13.8%) oocytes had an intact germinal vesicle (GV), 85 (39.3%) oocytes had undergone germinal vesicle breakdown (GVBD), 87 (40.2%) oocytes were arrested in metaphase II and 14 (6.5%) oocytes were atretic. After 5 h of culture in CMRL medium, 29 (34.1%) GVBD oocytes had matured to metaphase II arrest resulting in a total of 116 mature oocytes. Intracytoplasmic sperm injection (ICSI) was performed on metaphasearrested oocytes within 6 h post-isolation ( Figure 1A-E) . The injection pipette, containing a single spermatozoon, was introduced through the zona and pushed deep into the oocyte cytoplasm causing a slight invagination of the oolemma ( Figure 1A-C) . The injection pipette was withdrawn to the centre of the oocyte and the cytoplasm gently aspirated to ensure that the oolemma had been breached, at which point the oolemma resumed its shape ( Figure 1D ). The spermatozoa 3451 and aspirated cytoplasm were gently released into the centre of the oocyte prior to removal of the injection pipette. The site of injection is barely visible within 1 min post-injection ( Figure 1E ). Out of 116 metaphase-II arrested oocytes, 111 (95.6%) survived the injection process and by 15 h post-sperm injection, 85/111 (76.6 Ϯ SE 14.9%) had extruded the second polar body (PB) and developed two distinct pronuclei (Figure 2A) . Note the eccentric positioning of the pronuclei and the microtubule array emanating from the base of the male pronucleus ( Figure 2B ). Imaging the spermatozoa tail using differential interference contrast (DIC) microscopy confirmed the presence of a male pronucleus providing evidence that parthenogenesis did not occur ( Figure 2C ). Some oocytes which did not develop pronuclei were fixed to determine the cause of fertilization failure. The majority of these oocytes did not contain a spermatozoon and the oocyte remained arrested in meiosis. Furthermore, the formation of one or more than two pronuclei was rarely observed after ICSI (data not shown). Within 22 h post-ICSI (day 1), zygotes had completed first mitosis resulting in two, sometimes unequal, daughter blastomeres ( Figure 2D -F), often associated with small anucleate fragments. Following first mitosis, embryos were transferred to CMRL medium on a buffalo rat liver cell monolayer for co-culture.
On the morning of day 2 (approximately 36 h post-ICSI), embryos had cleaved to the 4-cell stage ( Figure 3A) . Cleavage to the 8-cell stage occurred late on day 2 within 60 h post-ICSI ( Figure 3B ). Subsequent cleavage divisions to the 16-cell and 32-cell stages ( Figures 3C and D, respectively) were slower, occurring approximately every 24 h. Morphologically, compacting ICSI embryos appeared uniform ( Figure 3E ) although the onset and duration of compaction was asynchronous, beginning as early as 120 h post-ICSI and being completed by 170 h post-ICSI. Arrest of ICSI embryos was greatest at the 32-cell stage (data not shown). Blastocoel fluid accumulation began as one or several small vacuoles ( Figure 3F ) which eventually coalesced to form a blastocoel cavity by approximately 180 h post-ICSI ( Figure 3G ). Blastocysts continued to expand for several days, eventually doubling in size until they reached approximately 260 µm ( Figure 3H ). Blastocyst hatching occurred at approximately 250 h post-ICSI ( Figure 3I ) and was completed within 6 h. It was not possible to express embryo development as a percentage of the total number of oocytes fertilized since some oocytes were either fixed at various stages of development to assess the normality of cleavage or frozen at the 2-to 8-cell stages for subsequent experiments.
Discussion
The results demonstrate that there are several features of rhesus intracytoplasmic sperm injection (ICSI) that were improved using in-vivo matured oocytes collected from gonadotrophinstimulated females when compared to ICSI of in-vitro matured rhesus oocytes collected from excized ovaries from nonstimulated females (Hewitson et al., 1996b) . The quality of oocytes from stimulated females was greatly improved resulting in a large number of mature oocytes per female. An additional oocyte activation signal or sperm immobilization prior to injection was not necessary to induce the resumption of meiosis after ICSI, and the success of fertilization after ICSI was dramatically improved using in-vivo matured oocytes.
Laparoscopic oocyte retrieval from gonadotrophin-stimulated rhesus monkeys produces relatively large numbers of developmentally competent oocytes (reviewed by Wolf et al., 1989) . In this study, a total of 216 oocytes were collected from eight females, 40% of which were mature at the time of oocyte retrieval. A short period of culture induced another 13% of oocytes to reach maturity and these were included in the study. The inclusion of these oocytes seemed justifiable since the timing of oocyte collection needs to be carefully monitored to prevent ovulation, often resulting in the retrieval of oocytes that are very close to completing maturation. Fertilization rates of laparoscopically-retrieved rhesus oocytes after ICSI was 76.6% (range 54.4-100%). This is comparable to recently published IVF data using rhesus oocytes obtained from gonadotrophin-stimulated females which resulted in an 88% fertilization rate, 11% of which were polyspermic (Schramm and Bavister, 1996) . In contrast, however, our earlier ICSI experiments using rhesus oocytes obtained from nonstimulated animals following ovariectomy and matured in vitro prior to fertilization only achieved a 25% success rate (Hewitson et al., 1996b) . The difference in ICSI fertilization rates using oocytes collected from either unstimulated or stimulated females can most likely be attributed to oocyte quality since oocytes obtained from relatively small, 3452 undeveloped follicles found in the ovaries of unstimulated females are unlikely to be developmentally competent even if a period of in-vitro culture can induce germinal vesicle breakdown and oocyte maturation. Rhesus oocytes matured in vitro from the germinal vesicle stage often display cytoskeletal abnormalities following fertilization by both IVF and ICSI including the inability to exit metaphase II of meiosis, meiotic arrest following the resumption of meiosis and the formation of multiple female karyomeres (pronuclei) after oocyte activation (Hewitson et al., 1996b; Sutovsky et al., 1996) . Conversely, fertilization failure after ICSI of rhesus oocytes derived from stimulated females was usually due to extrusion of the injected spermatozoa into the perivitelline space during subsequent invitro culture possibly due to insufficient cytoplasmic aspiration when depositing the spermatozoa.
Interestingly, ICSI of mature oocytes obtained from stimulated females resulted in oocyte activation without an additional chemical stimulus. In contrast, incubation in calcium ionophore was necessary to induce activation of in-vitro matured rhesus oocytes collected from unstimulated females after performing ICSI (Hewitson et al., 1996b) . Meng and Wolf (1997) demonstrated that microinjection of a rhesus sperm extract into mature rhesus oocytes induced oocyte activation and concluded that rhesus spermatozoa contain an oocyte-activating factor, perhaps localized in the sperm head. Whether the sperm extract would induce activation of in-vitro matured oocytes obtained from non-stimulated animals following ovariectomy, clearly material of questionable quality, was not determined. The only technical difference between rhesus and human ICSI is that human spermatozoa are subjected to 'rolling' to immobilize the spermatozoa prior to injection. This may result in modifications to the sperm plasma membrane aiding subsequent sperm decondensation (Fishel et al., 1995; Gerris et al., 1995) . Since the rhesus spermatozoa used for ICSI was obtained from fertile males and displayed normal semen characteristics in terms of morphology and motility, the additional rolling of the spermatozoa was not necessary to achieve fertilization. Performing ICSI using rhesus spermatozoa with poor semen characteristics will allow us to address whether rolling of the spermatozoa prior to ICSI improves the rate of fertilization when using compromised spermatozoa.
Epifluorescence microscopy of oocytes fertilized by ICSI revealed two eccentrically positioned pronuclei, one of which was associated with a sperm tail. A large microtubule aster emanating from the male pronucleus filled the entire oocyte cytoplasm, providing the microtubule-mediated motility necessary for pronuclear apposition and genomic union (Wu et al., 1996; Hewitson et al., 1996a) . This is particularly important for rhesus oocytes fertilized by ICSI since the spermatozoa is placed in a central position but then migrates to the oocyte cortex prior to first mitosis. This is in contrast to oocytes fertilized by IVF since the incorporated spermatozoa remains at the oocyte cortex during pronuclear formation and apposition (Sutovsky et al., 1996; Wu et al., 1996) . Fertilized rhesus ICSI embryos were co-cultured in a complex medium on a buffalo rat liver monolayer. Embryos underwent successive cleavage divisions resulting in large, hatched blastocysts 10 days post-ICSI. Since some ICSI embryos were either frozen for subsequent use or fixed to assess the normality of cleavage divisions, data on the percentage of fertilized embryos reaching each stage of development is not available. Interestingly, the timing of fertilization and subsequent embryo development after ICSI was similar to that of oocytes fertilized by IVF (Boatman, 1987) , although the conditions of embryo culture were different. For this study, a co-culture system was used to monitor the developmental potential of ICSI embryos since rhesus IVF embryos co-cultured with monolayers of epithelial (Goodeaux et al., 1990) , bovine oviductal (Zhang et al., 1993) and buffalo rat liver (Zhang et al., 1994) cells have consistently improved the rates of blastocyst formation. Initial experiments culturing rhesus IVF embryos in complex media without coculture were successful but resulted in arrest at the morula stage (Bavister et al., 1983) or in a reduced rate of blastocyst formation (Boatman, 1987) . More recently, rhesus IVF embryos have been cultured to the blastocyst stage in a chemically defined, protein-free culture medium, although their developmental potential was improved if embryos were cultured in a complex medium from the 8-to 12-cell stage onwards (Schramm and Bavister, 1996) . Whether a chemically-defined culture medium without co-culture, such as G1 and G2 used for human embyro culture (Gardner et al., 1997) will support the development of rhesus ICSI embryos to the blastocyst stage is now under investigation.
In conclusion, we have shown that oocytes retrieved by laparoscopy from gonadotrophin-stimulated rhesus monkeys result in high rates of fertilization after intracytoplasmic sperm injection (ICSI) and do not need an additional chemical stimulus to induce oocyte activation. Subsequent culture of rhesus ICSI embryos in CMRL medium on a buffalo rat liver cell monolayer culminated in hatched blastocysts 10 days after ICSI. The ability of rhesus ICSI embryos to implant, sustain a pregnancy and give rise to healthy offspring is currently being examined. Now that the applications of human ICSI have been extended to include patients with extreme male factor infertility, the need for a reliable non-human primate model is even more critical. The success of rhesus monkey ICSI underscores the rationale for using this non-human primate as a reliable model for examining many aspects of human ICSI. The successful propagation of non-human primates by ICSI, coupled with their short generational time, will permit an evaluation of the safety and biomedical basis of assisted reproductive technologies, for designing further improvements, as well as for exploring the realities of current clinical, and other unconventional, claims for alternative reproductive strategies.
